Therapeutic Implications of Cancer Stem Cell: Challenges and Opportunities in Translational Studies

作者: Chunguang Yang , Kunlin Jin , Yue Zhang , Hong Sun , William C. Cho

DOI: 10.1007/978-3-319-21030-8_19

关键词:

摘要: Cancer stem cells (CSCs) are rare in cancer population, but they can reconstruct the whole bulk of tumor if most killed by radiotherapy or chemotherapy. However, mechanism CSCs’ self-renewal, regeneration and therapeutic resistance is still unknown. Here we discuss role CSCs relapse progression, as well their diagnostic potentials. We also confer biomarkers pre-clinical models clinical trials to evaluate effectiveness CSCs. In addition, potential strategies eradicating tumors, such cytotoxic, radiation, signaling pathway differentiation therapies.

参考文章(117)
Tito Livraghi, Franca Meloni, Alberto Frosi, Sergio Lazzaroni, Mariano Bizzarri, Luigi Frati, Pier Mario Biava, Treatment with stem cell differentiation stage factors of intermediate-advanced hepatocellular carcinoma: an open randomized clinical trial. Oncology Research. ,vol. 15, pp. 399- 408 ,(2005) , 10.3727/096504005776449716
Venkatasubbaiah A. Venkatesha, Leslie A. Parsels, Joshua D. Parsels, Lili Zhao, Sonya D. Zabludoff, Diane M. Simeone, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan, Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition Neoplasia. ,vol. 14, pp. 519- 525 ,(2012) , 10.1593/NEO.12538
Max Schlaak, Patrick Schmidt, Christopher Bangard, Peter Kurschat, Cornelia Mauch, Hinrich Abken, Regression of metastatic melanoma by targeting cancer stem cells Oncotarget. ,vol. 3, pp. 22- 30 ,(2012) , 10.18632/ONCOTARGET.437
P O Humbert, N A Grzeschik, A M Brumby, R Galea, I Elsum, H E Richardson, Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene. ,vol. 27, pp. 6888- 6907 ,(2008) , 10.1038/ONC.2008.341
Hiroki Kuniyasu, Eiichi Tahara, Naohide Oue, Masahiro Tsutsumi, Wataru Yasui, Heparan Sulfate Enhances Invasion by Human Colon Carcinoma Cell Lines through Expression of CD44 Variant Exon 3 Clinical Cancer Research. ,vol. 7, pp. 4067- 4072 ,(2001)
Lilly YW Bourguignon, Zeenat Gunja‐Smith, Naoko Iida, HB Zhu, LJT Young, William J Muller, RD Cardiff, None, CD44v3,8–10 is involved in cytoskeleton‐mediated tumor cell migration and matrix metalloproteinase (MMP‐9) association in metastatic breast cancer cells Journal of Cellular Physiology. ,vol. 176, pp. 206- 215 ,(1998) , 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3
Kolja Eppert, Katsuto Takenaka, Eric R Lechman, Levi Waldron, Björn Nilsson, Peter van Galen, Klaus H Metzeler, Armando Poeppl, Vicki Ling, Joseph Beyene, Angelo J Canty, Jayne S Danska, Stefan K Bohlander, Christian Buske, Mark D Minden, Todd R Golub, Igor Jurisica, Benjamin L Ebert, John E Dick, Stem cell gene expression programs influence clinical outcome in human leukemia Nature Medicine. ,vol. 17, pp. 1086- 1093 ,(2011) , 10.1038/NM.2415
Jennifer B. Kum, Thomas M. Ulbright, Sean R. Williamson, Mingsheng Wang, Shaobo Zhang, Richard S. Foster, David J. Grignon, John N. Eble, Stephen D.W. Beck, Liang Cheng, Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell. The American Journal of Surgical Pathology. ,vol. 36, pp. 1849- 1856 ,(2012) , 10.1097/PAS.0B013E31826DF1AB
Tareq Al Baghdadi, Rafat Abonour, H. Scott Boswell, Novel Combination Treatments Targeting Chronic Myeloid Leukemia Stem Cells Clinical Lymphoma, Myeloma & Leukemia. ,vol. 12, pp. 94- 105 ,(2012) , 10.1016/J.CLML.2011.10.003